Clinical Pharmacology & Therapeutics · 1981 · 50 citations · 12 references
PharmacyPharmacokineticsPharmacologyDialysisHemodialysisRenal PharmacokineticsPharmacokinetics In Renal ImpairmentRenal ClearanceRenal DiseaseRenal Drug ClearanceRenal EliminationRenal PharmacologyDrug Clearance During HemodialysisDrug Elimination Half-lifeEliminationPharmacokinetics In Kidney DiseaseRenal Clearance KineticsRenal Elimination KineticsRenal Function Effects On ClearanceRenal Half-life
Kinetics of sotalol, a beta adrenoceptor blocker, was studied in 20 patients with varying renal function. In subjects with creatinine clearance (Clcr) greater than or equal to 39 ml/min/m2, sotalol plasma clearance (x +/- SD) was 71 +/- 31 ml/min/m2, elimination half-life (t 1/2) was 8.1 +/- 3.4 hr, and renal clearance was 46 +/- 26 ml/min/m2. In patients with moderate renal impairment (Clcr = 8 to 38 ml/min/m2) elimination t 1/2 rose to 24.2 +/- 7.5 hr, and plasma clearance fell to 24 +/- 7 ml/min/m2. In patients receiving dialysis, elimination t 1/2 rose to 33.9 +/- 27.1 hr. Elimination t 1/2 during hemodialysis was 5.8 +/- 2.1 hr and was associated with a 56.7 +/- 21% reduction in plasma levels.
12
Human Pharmacokinetics of Sotalol
Markku Anttila, M Arstila, Morris Pfeffer et al. · Acta Pharmacologica et Toxicologica · 1976 · 102 citations
Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.
Lish Pm, Shelanski Mv, Labudde Ja et al. · PubMed · 1967 · 38 citations